1. Home
  2. PRME vs HASI Comparison

PRME vs HASI Comparison

Compare PRME & HASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • HASI
  • Stock Information
  • Founded
  • PRME 2019
  • HASI 1981
  • Country
  • PRME United States
  • HASI United States
  • Employees
  • PRME N/A
  • HASI N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • HASI Real Estate Investment Trusts
  • Sector
  • PRME Health Care
  • HASI Real Estate
  • Exchange
  • PRME Nasdaq
  • HASI Nasdaq
  • Market Cap
  • PRME 191.7M
  • HASI 3.4B
  • IPO Year
  • PRME 2022
  • HASI 2013
  • Fundamental
  • Price
  • PRME $3.14
  • HASI $27.26
  • Analyst Decision
  • PRME Buy
  • HASI Strong Buy
  • Analyst Count
  • PRME 6
  • HASI 9
  • Target Price
  • PRME $9.38
  • HASI $38.33
  • AVG Volume (30 Days)
  • PRME 3.7M
  • HASI 1.8M
  • Earning Date
  • PRME 08-04-2025
  • HASI 07-31-2025
  • Dividend Yield
  • PRME N/A
  • HASI 6.16%
  • EPS Growth
  • PRME N/A
  • HASI N/A
  • EPS
  • PRME N/A
  • HASI 1.08
  • Revenue
  • PRME $3,846,000.00
  • HASI $126,702,000.00
  • Revenue This Year
  • PRME $104.12
  • HASI $189.49
  • Revenue Next Year
  • PRME $196.78
  • HASI $14.03
  • P/E Ratio
  • PRME N/A
  • HASI $25.23
  • Revenue Growth
  • PRME 550.76
  • HASI N/A
  • 52 Week Low
  • PRME $1.11
  • HASI $21.98
  • 52 Week High
  • PRME $6.75
  • HASI $36.56
  • Technical
  • Relative Strength Index (RSI)
  • PRME 79.25
  • HASI 55.82
  • Support Level
  • PRME $2.28
  • HASI $26.63
  • Resistance Level
  • PRME $2.78
  • HASI $28.42
  • Average True Range (ATR)
  • PRME 0.34
  • HASI 0.87
  • MACD
  • PRME 0.12
  • HASI 0.10
  • Stochastic Oscillator
  • PRME 81.62
  • HASI 63.64

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.

HA Sustainable Infrastructure Capital Inc is an investor in sustainable infrastructure assets advancing the energy transition. Its investment is focused on actively partnering with clients to deploy capital in income-generating real assets that are supported by long-term recurring cash flows. This enabled to the generation of attractive risk-adjusted returns and provided stockholders with diversified exposure to the energy transition.

Share on Social Networks: